Analytical methods : advancing methods and applications · 2026
Beyond conventional glucose assays: a dual smartphone-Arduino point-of-care diagnostic platform based on Fe-Zn bimetallic nanozymes.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hussein Ola G, Naguib Ibrahim A, Bayram Roula, Alluhayb Abdullah H, Ali Reham, Gamal Mohammed
Аннотация
The increasing demand for decentralized healthcare has accelerated the development of portable point-of-care (POC) diagnostic systems capable of providing rapid, accurate, and user-friendly glucose monitoring. Herein, we report an Fe-Zn bimetallic nanozyme-based colorimetric sensing platform that integrates smartphone-assisted digital image analysis and Arduino-based signal acquisition for portable glucose determination. The Fe-Zn bimetallic nanoparticles (Fe-Zn BNPs) were synthesized through a simple aqueous route and exhibited excellent intrinsic peroxidase-like activity toward the hydrogen peroxide-mediated oxidation of 3,3',5,5'-tetramethylbenzidine (TMB). Coupling the nanozyme with a glucose oxidase (GOx)-mediated cascade reaction enabled sensitive and selective glucose detection through catalytic signal amplification. The synthesized Fe-Zn BNPs exhibited excellent peroxidase-like catalytic activity toward hydrogen peroxide with a broad linear range of 10-700 µM and an excellent correlation coefficient (R2 = 0.9996). Steady-state kinetic analysis revealed a low apparent Km of 0.0647 mM and a Vmax of 1.75 × 10-9 M s-1 confirming the high substrate affinity and catalytic efficiency of the developed nanozyme. The proposed glucose sensing platform displayed a wide linear range of 10-500 µM with excellent analytical performance using UV-Vis spectrophotometry (R2 = 0.9980), Arduino-assisted detection (R2 = 0.9975), and smartphone-based digital image analysis (R2 = 0.9967). The platform demonstrated high selectivity toward glucose over common biological interferents and was successfully validated in human serum providing a glucose concentration of 5.07 ± 0.15 mM which was in excellent agreement with that of the reference clinical method (4.93 ± 0.14 mM). The environmental sustainability of the developed platform was comprehensively assessed using the Nanomaterial Assessment Tool (NAT), Blue Applicability Grade Index (BAGI), Red Analytical Performance Index (RAPI), and Environmental Performance-Practicality Index (EPPI) achieving scores of 78, 75, 70, and 84.8, respectively, demonstrating excellent compliance with the principles of green and white analytical chemistry. By integrating efficient Fe-Zn nanozyme catalysis with dual smartphone-Arduino portable detection, the proposed platform provides a sensitive, sustainable, and practical strategy for next-generation point-of-care glucose diagnostics.